^

Original-Research: NFON AG - from NuWays AG

09.01.2025 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to NFON AG

Company Name: NFON AG

ISIN: DE000A0N4N52

Reason for the research: Update

Recommendation: BUY

from: 09.01.2025

Target price: EUR 11.70

Target price on sight of: 12 months

Last rating change:

Analyst: Philipp Sennewald

NFON remains an Alpha pick after strong operations in FY24e

Topic: After a strong operating performance in FY24e, NFON looks set to

continuously expand margins at an increased top-line growth throughout

FY25e.

Sales in FY25e are expected to increase by 12.7% to EUR 97.1m (eNuW; eCons: EUR

95.2m) based on an increased cloud adoption and hence further key customer

wins in the company's key markets as well as the initial full FY

contribution of botario (acquisition closed in 09/24; eNuW: EUR 3.1m sales in

FY25e). Hereby, the share of recurring revenues looks set to further

increase to 94.6% (eNuW FY24e: 94.2%), given the decreasing importance of

hardware sales also in connection with new customer wins.

Moreover, we expect NFON to improve its adj. EBITDA to EUR 15.7m (eNuW; eCons:

EUR 14m unadj. EBITDA), implying disproportionate growth of 31% and a margin

of 16.2%. This should come on the back of an improved sales mix, meaning

less hardware sales as well as an increased ARPU following a higher share of

premium solutions sold, as well as cost saving measures imposed during

FY23/24, allowing for reduced personnel cost and marketing ratios. Also, the

botario acquisition (23.5% EBITDA margin in FY24e) will also be a main

driver of the margin expansion. Against this backdrop, FCF is seen to

improve to EUR 5.5m (eNuW: EUR 3.8m in FY24e).

Speaking of botario, we anticipate the acquisition to not only be margin

accretive but significantly enhance NFON's capabilities regarding AI and

process automation, thus marking a substantial competitive edge. In our

view, this should help the company gain additional market share in the still

highly fragmented market for integrated business communication going

forward.

Overall, the above is seen to allow for notably improving returns (eNuW:

ROIC 10% by FY25e) as well as cash generation, thus driving shareholder

value.

That said, current valuation remains highly attractive given that the stock

is trading on a 7.2x trailing EV/adj. EBITDA and a 5.2x EV/adj. EBITDA

FY25e. In our view, this is not justified, as it does not at all reflect the

significant operating improvements over the past 18 months.

We hence reiterate BUY with an unchanged PT of EUR 11.70, based on DCF, as

NFON remains part of our NuWays Alpha List.

You can download the research here: http://www.more-ir.de/d/31607.pdf

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---------------------------------------------------------------------------

2064081 09.01.2025 CET/CEST

°